Mounjaro, the star pharmaceutical from Eli Lilly, is experiencing a downturn in sales across India. This slump can be attributed to competi...

Cipla faces revenue and margin pressure due to the upcoming Revlimid patent expiry, leading to underperformance and analyst downgrades. Mar...

Torrent Pharma, currently seventh in India, is aimingto break into the top three drugmakers within five years through strategic acquisition...

The price range of the block is fixed at Rs 1,289-1,357, taking the total deal value to around Rs 2,637 crore.

Torrent Pharma's attempt to acquire the stake of the Hamied family in Cipla has hit a roadblock due to differences in valuation. Talks betw...

"As a policy we don't want to comment on speculative news," said Sudhir Menon, CFO of Torrent Pharma, referring to reports about the race t...

Consolidated net profit was 3.86 billion rupees ($46.4 million) for the quarter ended Sept. 30, compared with 3.12 billion rupees a year ea...

Cipla's potential stake sale faces a challenge due to disagreements among its promoters regarding the company's valuation. This dispute amo...

Torrent has also been in talks with CVC Capital Partners and Bain Capital who might become equity partners in a consortium and contribute a...

Torrent Pharmaceuticals is in advanced talks with CVC Capital Partners to raise at least $1.2-1.5 billion for its proposed acquisition of r...

Ahmedabad-based Torrent Pharma is seeking financing for a deal with Indian pharmaceutical company Cipla. Torrent Pharma is interested in bu...

Dr Reddy's said in a statement that it will not comment on market speculations over private equity (PE) firm Bain Capital approaching the c...

Private equity firm Bain Capital has approached Indian pharmaceutical company Dr Reddy's Laboratories (DRL) to explore a joint bid for the ...

Torrent Pharma has stated that it does not have any information to disclose under listing regulations, in response to reports about the com...

Rival contenders Blackstone, Baring Asia hit pause mode as Cipla valuations soar. Torrent taps PE funds like Warburg Pincus, CVC among othe...

Bernstein maintained an outperform rating on Cipla with a target price of Rs 1262. Cipla is a well-run organization. Blackstone will have t...

Torrent Pharma is reportedly vying to acquire the Hamied family's stake in Cipla, which could become the largest pharmaceutical deal since ...